Micropam

Diazepam, the active ingredient in Micropam, is a benzodiazepine presented as a rectal formulation for rectal use. It acts on the central nervous system to provide rapid relief of anxiety, control acute seizure activity, reduce muscle spasm, and alleviate symptoms associated with alcohol withdrawal in suitable patients.

GNH USA supplies Micropam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality compliance with EU standards and reliable global distribution, including timely logistics, regulatory support and after‑sales service.

Diazepam, a benzodiazepine, modulates GABA‑A receptors to treat several central nervous system conditions.

- Anxiety disorders: reduces excessive anxiety and tension. - Seizure disorders: controls acute seizure activity and status epilepticus. - Muscle spasm: relaxes skeletal muscle tone. - Alcohol withdrawal: mitigates tremor, agitation and risk of seizures.

Diazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness - Dizziness - Fatigue - Impaired coordination

Serious or Rare Side Effects: - Respiratory depression - Paradoxical agitation - Dependence and withdrawal syndrome

When prescribing Micropam, clinicians should consider several safety measures.

- Assess patient history: evaluate for respiratory depression, hepatic impairment, or glaucoma. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. - Monitor sedation: caution when operating machinery or driving. - Use with caution in elderly: increased sensitivity to CNS effects. - Pregnancy and lactation: assess risk–benefit, limited data available. - Store at room temperature: keep in original container, protect from moisture and light.

Diazepam interacts with various medicines; some combinations require avoidance, others close monitoring.

Major Interactions (Avoid): - CNS depressants (e.g., opioids, barbiturates): additive sedation and respiratory depression. - Azole antifungals (e.g., ketoconazole): increase diazepam plasma levels. - Macrolide antibiotics (e.g., erythromycin): may raise diazepam concentrations.

Moderate Interactions (Monitor Closely): - Antidepressants (e.g., SSRIs): may enhance CNS effects. - Antihistamines: increase sedation. - Alcohol: potentiates sedative effects.